1. Home
  2. List
Reference Patent

Reference - List

  • 49 Hits
  • Search Condition : Filter (MeSH = Antineoplastic Combined Chemotherapy Protocols / pharmacology*)
Species Resource Title
Human and Animal Cells TE-1(RCB1894) The Mechanism of the Synergistic Anticancer Effect of CDDP and EPA in the TE1 Cell Line.
Human and Animal Cells HuCCT1(RCB1960) Histone deacetylase inhibitor enhances the anti-tumor effect of gemcitabine: a special reference to gene-expression microarray analysis.
Human and Animal Cells TGBC1TKB(RCB1129) , TGBC2TKB(RCB1130) Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-κB.
Human and Animal Cells HMV-II(RCB0777) Combined inhibition of NF-κB and Bcl-2 triggers synergistic reduction of viability and induces apoptosis in melanoma cells.
Human and Animal Cells T24(RCB0431) Apoptosis of bladder cancer by sodium butyrate and cisplatin.
Human and Animal Cells PC-9(RCB4455) Favorable effect of the combination of vinorelbine and dihydropyrimidine dehydrogenase‑inhibitory fluoropyrimidine in EGFR‑mutated lung adenocarcinoma: retrospective and in vitro studies.
Human and Animal Cells HuH-7 HMDB and 5-AzadC Combination Reverses Tumor Suppressor CCAAT/Enhancer-Binding Protein Delta to Strengthen the Death of Liver Cancer Cells.
Human and Animal Cells HSC-2(RCB1945) ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma.
Human and Animal Cells StromaNKtert(RCB2350) AMG-176, an Mcl-1 Antagonist, Shows Preclinical Efficacy in Chronic Lymphocytic Leukemia.
Human and Animal Cells A549(RCB0098) Interleukin-6 blockade attenuates lung cancer tissue construction integrated by cancer stem cells.
Human and Animal Cells HCE-T(RCB2280) Venetoclax-based Rational Combinations are Effective in Models of MYCN-amplified Neuroblastoma.
Human and Animal Cells KGN(RCB1154) Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells.
Human and Animal Cells HuCCT1(RCB1960) , TFK-1(RCB2537) Therapeutic implication of HER2 in advanced biliary tract cancer.
Human and Animal Cells LM8(RCB1450) Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent and in combination with checkpoint-inhibitor therapy in mouse models of osteosarcoma.
Human and Animal Cells CACO-2(RCB0988) Perifosine enhances the potential antitumor effect of 5-fluorourasil and oxaliplatin in colon cancer cells harboring the PIK3CA mutation.
Human and Animal Cells RBE(RCB1292) , TFK-1(RCB2537) Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer.
Human and Animal Cells StromaNKtert(RCB2350) BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia.
Human and Animal Cells JHOM-1(RCB1676) , JHOM-2B(RCB1682) , OMC-3(RCB0755) Synergistic antitumor effects of combination PI3K/mTOR and MEK inhibition (SAR245409 and pimasertib) in mucinous ovarian carcinoma cells by fluorescence resonance energy transfer imaging.
Human and Animal Cells Jurkat(RCB0806) Selective Targeting of Cancerous Mitochondria and Suppression of Tumor Growth Using Redox-Active Treatment Adjuvant.
Human and Animal Cells MKN1(RCB1003) , MKN7(RCB0999) Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines.